SCHEMBL5166406

SCHEMBL5166406

CN(CCCCCC[C@H]1C[C@]2(C)[C@@H](O)CC[C@H]2[C@@H]2CCc3cc(O)ccc3[C@@H]12)CCCCCCC(F)(F)C(F)(F)F

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 15/20 0.67
ESR2 Q92731 9/20 0.67
CYP3A4 P08684 3/20 0.51
CYP2C19 P33261 3/20 0.51
NR3C1 P04150 2/20 0.51
PGR P06401 2/20 0.51
ESRRA P11474 2/20 0.51
CYP1A2 P05177 2/20 0.51
NR1I2 O75469 1/20 0.51
EPHX2 P34913 1/20 0.51
PPARG P37231 1/20 0.51
NR1H4 Q96RI1 1/20 0.51
SIRT5 Q9NXA8 1/20 0.51
ALOX15 P16050 1/20 0.51
HSD17B10 Q99714 3/20 0.48
LMNA P02545 2/20 0.48
TSHR P16473 2/20 0.48
CYP2C9 P11712 2/20 0.48
HIF1A Q16665 1/20 0.48
MEN1 O00255 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5165490 1.00 ESR1 (0.67) ESR1ESR2CYP3A4CYP2C19NR3C1
SCHEMBL5165894 1.00 ESR1 (0.67) ESR1ESR2CYP3A4CYP2C19NR3C1
SCHEMBL5167748 1.00 ESR1 (0.67) ESR1ESR2CYP3A4CYP2C19NR3C1
SCHEMBL5165547 1.00 ESR1 (0.67) ESR1ESR2CYP3A4CYP2C19NR3C1
SCHEMBL5169346 1.00 ESR1 (0.67) ESR1ESR2CYP3A4CYP2C19NR3C1
SCHEMBL5169580 0.98 ESR1 (0.67) ESR1ESR2CYP3A4CYP2C19NR3C1
SCHEMBL5169647 0.95 ESR1 (0.62) ESR1ESR2CYP3A4CYP2C19NR3C1
SCHEMBL5166437 0.94 ESR1 (0.64) ESR1ESR2CYP3A4CYP2C19NR3C1
SCHEMBL5166541 0.94 ESR1 (0.62) ESR1ESR2CYP3A4CYP2C19NR3C1
SCHEMBL5167865 0.94 ESR1 (0.63) ESR1ESR2CYP3A4CYP2C19NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1187846-B1 11BETA LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11BETA LONG-CHAIN SUBSTITUTED ESTRATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS BAYER SCHERING PHARMA AG (DE) 2007-04-18 EP claimed
US-6790842-B1 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 2004-09-14 US claimed
EP-1187846-B1 11BETA LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11BETA LONG-CHAIN SUBSTITUTED ESTRATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS BAYER SCHERING PHARMA AG (DE) 2007-04-18 EP disclosed
US-6790842-B1 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 2004-09-14 US disclosed